$0.0470
+0.0004 (+0.772%)
At Close: Jun 03, 2026
TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sci
PharmaTher Approved to Trade on the OTCQB Venture Market
08:30am, Wednesday, 13'th Jan 2021
TORONTO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF) (the "Company"), who through its wholly-owned subsidiary, PharmaTher Inc., is a specialty life scienc
PharmaTher Announces Application for OTCQB Listing
08:00am, Wednesday, 30'th Dec 2020
TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) (the “Company”), who through its wholly owned subsidiary, PharmaTher Inc., is a specialty life
Sign In
Buy PHRRF